IP41-14: Efficacy and Safety of Split-Dose Cisplatin Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: A Real-World Clinical Study

Saturday, May 16, 2026 1:00 PM to 3:00 PM · 1 hr. 59 min. (America/New_York)
147A
Abstract

Registered attendees

Hailong Liu
Hailong Liu
ResearcherXinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine

Log in

See all the content and easy-to-use features by logging in or registering!